New BHIVA guidelines on HIV care in pregnancy and after birth
Developmental problems of children born to women with HIV linked to substance use and HIV, not antiretrovirals
Dolutegravir: update on infant neural tube defects from Botswana
Dolutegravir-based ART recommended for all – if reliable contraception is available
Dolutegravir may cause birth defects, European Medicines Agency warns
High prevalence of menopausal symptoms in women living with HIV, but very few receive treatments for them
Efavirenz may undermine effectiveness of the vaginal ring contraceptive
